PGNY Q3 2025 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q3 2025 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$313M+9.3% YoY

Gross Profit

$73M23.2% margin

Operating Income

$22M6.9% margin

Net Income

$14M4.4% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

-5.9%

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$43M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$795M

Total Liabilities

$235M

Stockholders' Equity

$560M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$313M	$287M	+9.3%
Gross Profit	$73M	$59M	+22.9%
Operating Income	$22M	$12M	+72.8%
Net Income	$14M	$10M	+33.0%

Revenue Segments

Fertility benefit services revenue

$202M64%

Pharmacy benefit services revenue

$111M36%